OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, et al.
JAMA (2021) Vol. 326, Iss. 23, pp. 2375-2375
Open Access | Times Cited: 116
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, et al.
JAMA (2021) Vol. 326, Iss. 23, pp. 2375-2375
Open Access | Times Cited: 116
Showing 76-100 of 116 citing articles:
Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle
Zhigang Wang, Erwin Dreesen
Inflammatory Bowel Diseases (2023)
Closed Access | Times Cited: 3
Zhigang Wang, Erwin Dreesen
Inflammatory Bowel Diseases (2023)
Closed Access | Times Cited: 3
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies
Tsutomu Takeuchi, Kiyohiro Nishikawa, Fumika Yamada, et al.
Drug Safety (2023) Vol. 46, Iss. 10, pp. 991-1005
Open Access | Times Cited: 3
Tsutomu Takeuchi, Kiyohiro Nishikawa, Fumika Yamada, et al.
Drug Safety (2023) Vol. 46, Iss. 10, pp. 991-1005
Open Access | Times Cited: 3
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis
Wen‐Liang Dong, Xiaowen Hu, Caiying Wu, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152302-152302
Closed Access | Times Cited: 3
Wen‐Liang Dong, Xiaowen Hu, Caiying Wu, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152302-152302
Closed Access | Times Cited: 3
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases
Silje Watterdal Syversen, Johanna Elin Gehin, Guro Løvik Goll, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 5, pp. 667-669
Open Access | Times Cited: 3
Silje Watterdal Syversen, Johanna Elin Gehin, Guro Løvik Goll, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 5, pp. 667-669
Open Access | Times Cited: 3
Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease
Lidia Díaz, Carles Iniesta Navalón, Rosa Gómez Espín, et al.
Gastroenterología y Hepatología (2022) Vol. 46, Iss. 7, pp. 504-511
Closed Access | Times Cited: 5
Lidia Díaz, Carles Iniesta Navalón, Rosa Gómez Espín, et al.
Gastroenterología y Hepatología (2022) Vol. 46, Iss. 7, pp. 504-511
Closed Access | Times Cited: 5
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
Mathilde Leclercq, Paul Goupillou, H.D. Escobar Gómez, et al.
Journal of Ophthalmic Inflammation and Infection (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Mathilde Leclercq, Paul Goupillou, H.D. Escobar Gómez, et al.
Journal of Ophthalmic Inflammation and Infection (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience
Antony Raharja, Zehra Arkir, Giulia Rinaldi, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1708-1716.e4
Open Access | Times Cited: 2
Antony Raharja, Zehra Arkir, Giulia Rinaldi, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1708-1716.e4
Open Access | Times Cited: 2
Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: a case report and literature review
Marouf Alhalabi, Kamal Alaa Eddin, Ahmad Abbas
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 11, pp. 1298-1305
Closed Access | Times Cited: 2
Marouf Alhalabi, Kamal Alaa Eddin, Ahmad Abbas
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 11, pp. 1298-1305
Closed Access | Times Cited: 2
Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
Yago González‐Lama, Elena Ricart, Daniel Carpio, et al.
BMJ Open Gastroenterology (2024) Vol. 11, Iss. 1, pp. e001246-e001246
Open Access
Yago González‐Lama, Elena Ricart, Daniel Carpio, et al.
BMJ Open Gastroenterology (2024) Vol. 11, Iss. 1, pp. e001246-e001246
Open Access
Principles of Systemic Therapy
Andrew Pink, Richard Woolf, Catherine Smith
(2024), pp. 1-56
Closed Access
Andrew Pink, Richard Woolf, Catherine Smith
(2024), pp. 1-56
Closed Access
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access
Antidrug Antibody, Therapeutic Drug Monitoring: Status Update and Future Directions in Spondyloarthritis
Dae‐Hyun Yoo
Arthritis & Rheumatology (2024) Vol. 76, Iss. 12, pp. 1699-1701
Closed Access
Dae‐Hyun Yoo
Arthritis & Rheumatology (2024) Vol. 76, Iss. 12, pp. 1699-1701
Closed Access
Evaluating the Efficacy of Infliximab in Inflammatory Bowel Disease: A Systematic Review of the Literature
Maria P Vallejo, Arturo P Jaramillo, Carlos Luis Guanín Cabrera, et al.
Cureus (2024)
Open Access
Maria P Vallejo, Arturo P Jaramillo, Carlos Luis Guanín Cabrera, et al.
Cureus (2024)
Open Access
Comparative Efficacy of Anti-tumor Necrosis Factor (TNF) Therapy in Inducing and Maintaining Remission from Crohn's Disease: A Systematic Review and Meta-analysis
Muhammad Sohail S. Mirza, Maria Khan, Md S. Rahman, et al.
Journal of Advances in Medicine and Medical Research (2024) Vol. 36, Iss. 9, pp. 105-121
Open Access
Muhammad Sohail S. Mirza, Maria Khan, Md S. Rahman, et al.
Journal of Advances in Medicine and Medical Research (2024) Vol. 36, Iss. 9, pp. 105-121
Open Access
Model-informed precision dosing in inflammatory bowel diseases
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Adalimumab Autoantibodies in Uveitis Patients: Do We Need Routine Drug Monitoring?
Lynn S. zur Bonsen, Vitus A. Knecht, Anne Rübsam, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2782-2782
Open Access
Lynn S. zur Bonsen, Vitus A. Knecht, Anne Rübsam, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2782-2782
Open Access
A simple automated assay format for measuring multiple immune checkpoint inhibitors
Ragnhild V. Nome, Øystein Flatebø, Sigurd Leinæs Bøe, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 255, pp. 116657-116657
Closed Access
Ragnhild V. Nome, Øystein Flatebø, Sigurd Leinæs Bøe, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 255, pp. 116657-116657
Closed Access
Therapeutic drug monitoring countering the effect of anti-infliximab antibodies
Femke Hooijberg, Gertjan Wolbink
The Lancet Rheumatology (2024) Vol. 6, Iss. 4, pp. e193-e194
Closed Access
Femke Hooijberg, Gertjan Wolbink
The Lancet Rheumatology (2024) Vol. 6, Iss. 4, pp. e193-e194
Closed Access
Improved high‐performance liquid chromatography tandem mass spectrometry method for quantification of infliximab in pediatric plasma and its application in therapeutic drug monitoring
Boran Yu, Siyao Jin, Jiaqi Han, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 18
Closed Access
Boran Yu, Siyao Jin, Jiaqi Han, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 18
Closed Access
Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation
Carley Karsten, Karin Grannas, Oskar Bergman, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Open Access
Carley Karsten, Karin Grannas, Oskar Bergman, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Open Access
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Therapeutic drug monitoring for immune mediated inflammatory diseases
Neil Chanchlani, Z.Z.N. Yiu, Lisa K. Stamp, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001130-e001130
Open Access
Neil Chanchlani, Z.Z.N. Yiu, Lisa K. Stamp, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001130-e001130
Open Access
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, et al.
RMD Open (2024) Vol. 10, Iss. 4, pp. e004888-e004888
Open Access
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, et al.
RMD Open (2024) Vol. 10, Iss. 4, pp. e004888-e004888
Open Access
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study
Thanaboon Chaemsupaphan, Aviv Pudipeddi, Hui-Yu Lin, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 2
Closed Access
Thanaboon Chaemsupaphan, Aviv Pudipeddi, Hui-Yu Lin, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 2
Closed Access
